More information about a person's genetic makeup, drug response, multi-omics response,
and genomic response is now available leading to a gradual shift towards personalized …

Personalized medicine tailors therapies, disease prevention, and health maintenance to the
individual, with pharmacogenomics serving as a key tool to improve outcomes and prevent …

Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular
disease (CVD) deaths in the USA and around the globe. Due to the complex nature …

Artificial intelligence (AI) is rapidly becoming an established arm in medical sciences and
clinical practice in numerous medical fields. Its implications have been rising and are being …

Cardiovascular disease (CVD) is the leading cause of mortality and loss of disability
adjusted life years (DALYs) globally. CVDs like Heart Failure (HF) and Atrial Fibrillation (AF) …

Personalized interventions are deemed vital given the intricate characteristics,
advancement, inherent genetic composition, and diversity of cardiovascular diseases …

AI-assisted screening and prevention programs have the potential to revolutionize disease
management and improve public health outcomes. By harnessing the power of artificial …

Precision medicine is a growing field in critical care. Research increasingly demonstrated
pharmacogenomic variability to be an important determinant of analgesic and sedative drug …

With climate emergency, COVID-19, and the rise of planetary health scholarship, the binary
of human and ecosystem health has been deeply challenged. The interdependence of …

Due to the advancements in sequencing technologies, genomics data is developing at an
unmatched pace and levels to foster translational research. Over ten million genomics …